Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2

Journal of Immunology

Volumn 188, Issue 8, 2012, Pages 3876-3885

  Zaritsky, Luna Alammar ^a   Gama, Lucio ^a   Clements, Janice E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE RECEPTOR CCR2; INTERFERON; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYXOVIRUS RESISTANCE PROTEIN A;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; INNATE IMMUNITY; MACACA; MACROPHAGE; MXA GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TRAIL GENE; VIRUS CELL INTERACTION; VIRUS INHIBITION;

ANIMALS; ASTROCYTES; BRAIN; CELL COMMUNICATION; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-BETA; MACACA MULATTA; MACROPHAGES; PRIMARY CELL CULTURE; RECEPTORS, CCR2; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; VIRUS REPLICATION;

EID: 84860346298     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103024     Document Type: Article

References (60)

1. Kawai, T., and S. Akira. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141: 137-145. (Pubitemid 46775751)
2. Alammar, L., L. Gama, and J. E. Clements. 2011. Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. J. Immunol. 186: 4008-4018.
3. Rani, M. R., and R. M. Ransohoff. 2005. Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J. Interferon Cytokine Res. 25: 788-798. (Pubitemid 43068490)
4. van Heteren, J. T., F. Rozenberg, E. Aronica, D. Troost, P. Lebon, and T. W. Kuijpers. 2008. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutières syndrome. Glia 56: 568-578.
5. Crow, Y. J., D. N. Black, M. Ali, J. Bond, A. P. Jackson, M. Lefson, J. Michaud, E. Roberts, J. B. Stephenson, C. G. Woods, and P. Lebon. 2003. Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J. Med. Genet. 40: 183-187. (Pubitemid 36315389)
6. Schaefer, M., M. A. Engelbrecht, O. Gut, B. L. Fiebich, J. Bauer, F. Schmidt, H. Grunze, and K. Lieb. 2002. Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry 26: 731-746. (Pubitemid 34615979)
7. Ban, M., A. Goris, A. R. Lorentzen, A. Baker, T. Mihalova, G. Ingram, D. R. Booth, R. N. Heard, G. J. Stewart, E. Bogaert, et al; Wellcome Trust Case-Control Consortium (WTCCC). 2009. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. 17: 1309-1313.
8. Rho, M. B., S. Wesselingh, J. D. Glass, J. C. McArthur, S. Choi, J. Griffin, and W. R. Tyor. 1995. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain Behav. Immun. 9: 366-377. (Pubitemid 26039775)
9. Chabot, S., and V. W. Yong. 2000. Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS. Neurology 55: 1497-1505.
10. Paul, S., C. Ricour, C. Sommereyns, F. Sorgeloos, and T. Michiels. 2007. Type I interferon response in the central nervous system. Biochimie 89: 770-778. (Pubitemid 47008947)
11. Davis, L. E., B. L. Hjelle, V. E. Miller, D. L. Palmer, A. L. Llewellyn, T. L. Merlin, S. A. Young, R. G. Mills, W. Wachsman, and C. A. Wiley. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736-1739.
12. An, S. F., B. Giometto, and F. Scaravilli. 1996. HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann. Neurol. 40: 611-617. (Pubitemid 26357886)
13. Overholser, E. D., G. D. Coleman, J. L. Bennett, R. J. Casaday, M. C. Zink, S. A. Barber, and J. E. Clements. 2003. Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J. Virol. 77: 6855-6866. (Pubitemid 36666879)
14. Buckner, C. M., T. M. Calderon, D. W. Willams, T. J. Belbin, and J. W. Berman. 2011. Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. Cell. Immunol. 267: 109-123.
15. Persidsky, Y., M. Stins, D. Way, M. H. Witte, M. Weinand, K. S. Kim, P. Bock, H. E. Gendelman, and M. Fiala. 1997. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158: 3499-3510. (Pubitemid 127484072)
16. Nottet, H. S., Y. Persidsky, V. G. Sasseville, A. N. Nukuna, P. Bock, Q. H. Zhai, L. R. Sharer, R. D. McComb, S. Swindells, C. Soderland, and H. E. Gendelman. 1996. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156: 1284-1295. (Pubitemid 26048128)
17. van't Wout, A. B., L. J. Ran, C. L. Kuiken, N. A. Kootstra, S. T. Pals, and H. Schuitemaker. 1998. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J. Virol. 72: 488-496. (Pubitemid 28048863)
18. Mankowski, J. L., D. L. Carter, J. P. Spelman, M. L. Nealen, K. R. Maughan, L. M. Kirstein, P. J. Didier, R. J. Adams, M. Murphey-Corb, and M. C. Zink. 1998. Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus. Am. J. Pathol. 153: 1123-1130. (Pubitemid 28465835)
19. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093. (Pubitemid 16032241)
20. Wiley, C. A., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. Oldstone. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83: 7089-7093. (Pubitemid 16002375)
21. Barber, S. A., L. Gama, J. M. Dudaronek, T. Voelker, P. M. Tarwater, and J. E. Clements. 2006. Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J. Infect. Dis. 193: 963-970.
22. Dudaronek, J. M., S. A. Barber, and J. E. Clements. 2007. CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages. J. Immunol. 179: 7262-7269.
23. Giulian, D., K. Vaca, and C. A. Noonan. 1990. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593-1596. (Pubitemid 120034376)
24. Kaul, M., J. Zheng, S. Okamoto, H. E. Gendelman, and S. A. Lipton. 2005. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12(Suppl 1): 878-892. (Pubitemid 41038393)
25. Bsibsi, M., R. Ravid, D. Gveric, and J. M. van Noort. 2002. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61: 1013-1021. (Pubitemid 35278723)
26. Farina, C., M. Krumbholz, T. Giese, G. Hartmann, F. Aloisi, and E. Meinl. 2005. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159: 12-19. (Pubitemid 40126172)
27. Barres, B. A. 2008. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60: 430-440.
28. Ranki, A., M. Nyberg, V. Ovod, M. Haltia, I. Elovaara, R. Raininko, H. Haapasalo, and K. Krohn. 1995. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9: 1001-1008.
29. Soulas, C., C. Conerly, W. K. Kim, T. H. Burdo, X. Alvarez, A. A. Lackner, and K. C. Williams. 2011. Recently infiltrating MAC387(+) monocytes/macrophages a third macrophage population involved in SIV and HIV encephalitic lesion formation. Am. J. Pathol. 178: 2121-2135.
30. Eugenin, E. A., T. G. D'Aversa, L. Lopez, T. M. Calderon, and J. W. Berman. 2003. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 85: 1299-1311. (Pubitemid 36613277)
31. Meda, L., M. A. Cassatella, G. I. Szendrei, L. Otvos, Jr., P. Baron, M. Villalba, D. Ferrari, and F. Rossi. 1995. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374: 647-650.
32. Matsumoto, H., Y. Kumon, H. Watanabe, T. Ohnishi, M. Shudou, C. Ii, H. Takahashi, Y. Imai, and J. Tanaka. 2007. Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J. Neurosci. Res. 85: 994-1009. (Pubitemid 46580341)
33. Vincent, V. A., F. J. Tilders, and A. M. Van Dam. 1997. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta. Glia 19: 190-198. (Pubitemid 27140906)
34. Aloisi, F., G. Borsellino, A. Caré, U. Testa, P. Gallo, G. Russo, C. Peschle, and G. Levi. 1995. Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain. Int. J. Dev. Neurosci. 13: 265-274.
35. Min, K. J., M. S. Yang, S. U. Kim, I. Jou, and E. H. Joe. 2006. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J. Neurosci. 26: 1880-1887. (Pubitemid 43237001)
36. Kim, J. H., K. J. Min, W. Seol, I. Jou, and E. H. Joe. 2010. Astrocytes in injury states rapidly produce anti-inflammatory factors and attenuate microglial inflammatory responses. J. Neurochem. 115: 1161-1171.
37. Nottet, H. S., M. Jett, C. R. Flanagan, Q. H. Zhai, Y. Persidsky, A. Rizzino, E. W. Bernton, P. Genis, T. Baldwin, J. Schwartz, et al. 1995. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154: 3567-3581.
38. Co, J. G., K. W. Witwer, L. Gama, M. C. Zink, and J. E. Clements. 2011. Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. J. Infect. Dis. 204: 1104-1114.
39. Overholser, E. D., T. Babas, M. C. Zink, S. A. Barber, and J. E. Clements. 2005. CD4-independent entry and replication of simian immunodeficiency virus in primary rhesus macaque astrocytes are regulated by the transmembrane protein. J. Virol. 79: 4944-4951. (Pubitemid 40464245)
40. Sabri, F., E. Tresoldi, M. Di Stefano, S. Polo, M. C. Monaco, A. Verani, J. R. Fiore, P. Lusso, E. Major, F. Chiodi, and G. Scarlatti. 1999. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 264: 370-384.
41. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360. (Pubitemid 44354220)
42. Conant, K., A. Garzino-Demo, A. Nath, J. C. McArthur, W. Halliday, C. Power, R. C. Gallo, and E. O. Major. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95: 3117-3121. (Pubitemid 28135864)
43. Zink, M. C., G. D. Coleman, J. L. Mankowski, R. J. Adams, P. M. Tarwater, K. Fox, and J. E. Clements. 2001. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J. Infect. Dis. 184: 1015-1021. (Pubitemid 32955118)
44. Yokochi, S., H. Hashimoto, Y. Ishiwata, H. Shimokawa, M. Haino, Y. Terashima, and K. Matsushima. 2001. An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2. J. Interferon Cytokine Res. 21: 389-398. (Pubitemid 32692460)
45. Liu, Y., H. Liu, B. O. Kim, V. H. Gattone, J. Li, A. Nath, J. Blum, and J. J. He. 2004. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J. Virol. 78: 4120-4133. (Pubitemid 38437218)
46. Witwer, K. W., L. Gama, M. Li, C. M. Bartizal, S. E. Queen, J. J. Varrone, A. K. Brice, D. R. Graham, P. M. Tarwater, J. L. Mankowski, et al. 2009. Coordinated regulation of SIV replication and immune responses in the CNS. PLoS ONE 4: e8129.
47. Brack-Werner, R. 1999. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13: 1-22.
48. Boutros, T., E. Croze, and V. W. Yong. 1997. Interferon-beta is a potent promoter of nerve growth factor production by astrocytes. J. Neurochem. 69: 939-946. (Pubitemid 27364813)
49. Bruno, V., A. Copani, G. Besong, G. Scoto, and F. Nicoletti. 2000. Neuro-protective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 399: 117-121. (Pubitemid 30407031)
50. Hinojosa, A. E., B. Garcia-Bueno, J. C. Leza, and J. L. Madrigal. 2011. CCL2/MCP-1 modulation of microglial activation and proliferation. J. Neuro-inflammation 8: 77.
51. El Khoury, J., M. Toft, S. E. Hickman, T. K. Means, K. Terada, C. Geula, and A. D. Luster. 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13: 432-438. (Pubitemid 46559828)
52. Hokeness, K. L., W. A. Kuziel, C. A. Biron, and T. P. Salazar-Mather. 2005. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174: 1549-1556.
53. Jia, T., I. Leiner, G. Dorothee, K. Brandl, and E. G. Pamer. 2009. MyD88 and type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection. J. Immunol. 183: 1271-1278.
54. Nakamura, S., K. M. Davis, and J. N. Weiser. 2011. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121: 3657-3665.
55. Zimmerer, J. M., G. B. Lesinski, M. D. Radmacher, A. Ruppert, and W. E. Carson, III. 2007. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha. Cancer Immunol. Immunother. 56: 1845-1852. (Pubitemid 47313088)
56. Ishiwata, Y., S. Yokochi, E. Suzuki, H. Michishita, A. Tashita, K. Asano, T. Mitani, and M. Kurono. 1990. Effects of proxigermanium on interferon production and 2',5'-oligoadenylate synthetase activity in the lung of influenza virus-infected mice and in virus-infected human peripheral blood mononuclear cell cultures. Arzneimittelforschung 40: 896-899. (Pubitemid 20241086)
57. Munakata, T., S. Arai, K. Kuwano, M. Furukawa, and Y. Tomita. 1987. Induction of interferon production by natural killer cells by organogermanium compound, Ge132. J. Interferon Res. 7: 69-76. (Pubitemid 17154696)
58. Aso, H., F. Suzuki, T. Yamaguchi, Y. Hayashi, T. Ebina, and N. Ishida. 1985. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol. Immunol. 29: 65-74. (Pubitemid 15166251)
59. Sun, Y., D. McGarrigle, and X. Y. Huang. 2007. When a G protein-coupled receptor does not couple to a G protein. Mol. Biosyst. 3: 849-854. (Pubitemid 350115412)
60. Mellado, M., J. M. Rodríguez-Frade, A. Aragay, G. del Real, A. M. Martín, A. J. Vila-Coro, A. Serrano, F. Mayor, Jr., and C. Martínez-A. 1998. The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J. Immunol. 161: 805-813. (Pubitemid 28323544)